References
- Ito Y, Bae S-C, Chuang LSH. The RUNX family: developmental regulators in cancer. Nat Rev Cancer 2015; 15:81-95; PMID:25592647; http://dx.doi.org/10.1038/nrc3877
- Chuang LSH, Lai SK, Murata-Hori M, Yamada A, Li H-Y, Gunaratne J, Ito Y. RUNX3 interactome reveals novel centrosomal targeting of RUNX family of transcription factors. Cell Cycle 2012; 11:1938-47; PMID:22544322; http://dx.doi.org/10.4161/cc.20278
- Chuang LSH, Khor JM, Lai SK, Garg S, Krishnan V, Koh C-G, Lee SH, Ito Y. Aurora kinase-induced phosphorylation excludes transcription factor RUNX from the chromatin to facilitate proper mitotic progression. Proc Natl Acad Sci U S A 2016; 113:6490-5; PMID:27217562; http://dx.doi.org/10.1073/pnas.1523157113
- Bravo J, Li Z, Speck NA, Warren AJ. The leukemia-associated AML1 (Runx1)–CBFβ complex functions as a DNA-induced molecular clamp. Nat Struct Biol 2001; 8:371-8; PMID:11276260; http://dx.doi.org/10.1038/86264
- Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014; 513:202-9; PMID:25079317; http://dx.doi.org/10.1038/nature13480
- Lee Y-S, Lee J-W, Jang J-W, Chi X-Z, Kim J-H, Li Y-H, Kim M-K, Kim D-M, Choi B-S, Kim E-G, et al. Runx3 inactivation is a crucial early event in the development of lung Adenocarcinoma. Cancer Cell 2013; 24:603-16; PMID:24229708; http://dx.doi.org/10.1016/j.ccr.2013.10.003
- Wang CQ, Krishnan V, Tay LS, Chin DWL, Koh CP, Chooi JY, Nah GSS, Du L, Jacob B, Yamashita N, et al. Disruption of Runx1 and Runx3 leads to bone marrow failure and Leukemia predisposition due to transcriptional and DNA repair defects. Cell Rep 2014; 8:767-82; PMID:25066130; http://dx.doi.org/10.1016/j.celrep.2014.06.046